Valeant Pharmaceuticals International (VRX) Completes Acquisition Of Xcel Pharmaceuticals, Inc.
10/19/2005 5:12:53 PM
More...
|
Valeant Pharmaceuticals International (VRX) To Acquire Xcel Pharmaceuticals, Inc.; Acquisition Expands Valeant's Neurology Franchise In North America; Adds Retigabine To Pipeline
10/19/2005 5:12:36 PM
More...
|
Pozen, Inc. (POZN) Receives Positive News On MT 100 In The U.K.
10/19/2005 5:12:33 PM
More...
|
Xcel Pharmaceuticals, Inc. Pulls IPO Plan, Cites Market Conditions; $75 Million
10/19/2005 5:10:50 PM
More...
|
Xcel Pharmaceuticals, Inc. Acquires Retigabine, A Late-Stage Development Product Candidate For Epilepsy
10/19/2005 5:09:53 PM
More...
|
The Day In Review: Biotech Lower After Fed Decision
10/19/2005 5:09:02 PM
More...
|
Par Pharmaceutical Companies, Inc. (PRX) Comments On Diastat(R) Litigation
10/19/2005 5:08:58 PM
More...
|